Posted on Monday, September 21, 2020 By Rebecca Wilkes
Manchester, UK - Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that it has appointed Immuno-Biological Laboratories Inc (‘IBL-America’), a supplier of in-vitro diagnostic kits for the medical device and research industry, as a non-exclusive distributor for several PCR (‘polymerase chain reaction’) tests across Yourgene’s reproductive health and oncology portfolios in the US.
Posted on Monday, September 21, 2020 By Rebecca Wilkes
As the country returns to some semblance of normality, despite the recent guidelines, I’d like to take the opportunity to bring our Members, Sponsors and Supporters up to date with the world of OBN.
OBN responded quickly and decisively to the unprecedented challenge that COVID 19, the lockdown and subsequent restrictions brought and I am delighted and proud of the OBN team’s response to such extraordinary circumstances, not least of which entailed the successful transformation of BioTrinity® from a physical event to become the UK’s first fully digital conference in the tightest of timescales.
Posted on Thursday, September 17, 2020 By Rebecca Wilkes
The Oxford Trust, the charity encouraging the pursuit of science and enterprise, has welcomed five new occupiers during lockdown across its two Oxford innovation centres: The Oxford Centre for Innovation next to Oxford Castle and The Wood Centre for Innovation in Headington’s Global Health & Life Sciences District. In addition, two current occupiers have taken expansion space, bringing the total new space taken during lockdown to 4,000 sq ft.
Posted on Wednesday, September 16, 2020 By Rebecca Wilkes
Arctoris, the creator of the world’s first fully automated drug discovery platform, has signed a Memorandum of Understanding with listed Korean company Syntekabio, Inc. to collaborate on drug discovery efforts. The first project under the agreement sees the two companies work together to assess small molecule therapeutics for COVID-19.
Posted on Wednesday, September 9, 2020 By Rebecca Wilkes
Norman Disney Young, a global engineering consultancy, is delighted to welcome Rui Dinis to Head the UK Life Sciences Team. Rui has over 20 years working in the Life Sciences sector, successfully developing relationships and opportunities, implementing best practices to ensure compliance and execution of stringent regulatory guidelines in regulated and emerging markets. From startups to long established and leading names in the sector, his proven experience has resulted in significant added value to the clients he worked with.
Posted on Wednesday, September 9, 2020 By Rebecca Wilkes
We are pleased to announce details of the companies that have been shortlisted to the final round of the 12th Annual OBN Awards, the most highly regarded awards event in the life sciences industry.
Posted on Thursday, September 3, 2020 By Rebecca Wilkes
OXFORD, UK – 03 September 2020 – Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting serious diseases, is delighted to announce its partnership with the University of Adelaide to develop a new thermostable, solid dose DNA vaccine for Zika virus to prevent infection of pregnant women and the resultant congenital effects in the unborn child.
Posted on Thursday, September 3, 2020 By Rebecca Wilkes
Manchester, UK : Yourgene (AIM: YGEN), the international molecular diagnostics group, announced today the launch of IONA® Nx NIPT workflow, the Company’s new innovative non-invasive prenatal test (‘NIPT’). The IONA Nx seeks to offer clinical labs a high performing, flexible, scalable and innovative NIPT service inhouse and is developed to run on the Illumina Nextseq 550 Dx platform for next generation sequencing.
Posted on Wednesday, September 2, 2020 By Rebecca Wilkes
Executive search consultancy, Horton International UK, has announced the appointment of Mark Johnson as Senior Partner of its Oxford-based Global Healthcare arm.
Posted on Wednesday, September 2, 2020 By Rebecca Wilkes
AMSBIO announce new additions and certifications for their market-leading range of clinical grade, chemically defined cryopreservation excipient solutions - STEM-CELLBANKER® and HSC-BANKER®.
STEM-CELLBANKER® DMSO Free GMP grade is a new chemically defined freezing solution that does not contain DMSO as an anti-freezing agent. It was developed for customers who prefer not to use DMSO-containing cryopreservation solution due to the intended application of the samples. STEM-CELLBANKER® DMSO Free GMP grade is manufactured in compliance with JPN, EU, US, and PIC/S GMP guidelines.